NO863321L - Fysikalsk modifisert beclomethasondipropionat egnet for anvendelse i aerosoler. - Google Patents

Fysikalsk modifisert beclomethasondipropionat egnet for anvendelse i aerosoler.

Info

Publication number
NO863321L
NO863321L NO863321A NO863321A NO863321L NO 863321 L NO863321 L NO 863321L NO 863321 A NO863321 A NO 863321A NO 863321 A NO863321 A NO 863321A NO 863321 L NO863321 L NO 863321L
Authority
NO
Norway
Prior art keywords
beclomethasondipropionate
aerosols
physically modified
physically
modified
Prior art date
Application number
NO863321A
Other languages
English (en)
Other versions
NO170516C (no
NO170516B (no
NO863321D0 (no
Inventor
Philip Anthony Jinks
Original Assignee
Riker Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Riker Laboratories Inc filed Critical Riker Laboratories Inc
Publication of NO863321L publication Critical patent/NO863321L/no
Publication of NO863321D0 publication Critical patent/NO863321D0/no
Publication of NO170516B publication Critical patent/NO170516B/no
Publication of NO170516C publication Critical patent/NO170516C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
    • C07J5/0061—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16
    • C07J5/0069—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group
    • C07J5/0076—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group by an alkyl group

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicinal Preparation (AREA)
NO863321A 1984-12-19 1986-08-18 Fremgangsmaate for fremstilling av en formulering av beclomethasondipropionat NO170516C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB848432063A GB8432063D0 (en) 1984-12-19 1984-12-19 Physically modified steroids
PCT/GB1985/000588 WO1986003750A1 (en) 1984-12-19 1985-12-16 Physically modified beclomethasone dipropionate suitable for use in aerosols

Publications (4)

Publication Number Publication Date
NO863321L true NO863321L (no) 1986-08-18
NO863321D0 NO863321D0 (no) 1986-08-18
NO170516B NO170516B (no) 1992-07-20
NO170516C NO170516C (no) 1992-10-28

Family

ID=10571434

Family Applications (1)

Application Number Title Priority Date Filing Date
NO863321A NO170516C (no) 1984-12-19 1986-08-18 Fremgangsmaate for fremstilling av en formulering av beclomethasondipropionat

Country Status (14)

Country Link
US (1) US4810488A (no)
EP (1) EP0205530B1 (no)
JP (1) JPH0714880B2 (no)
KR (1) KR910004338B1 (no)
AU (1) AU587010B2 (no)
CA (1) CA1253806A (no)
DE (1) DE3568334D1 (no)
ES (1) ES8702136A1 (no)
GB (1) GB8432063D0 (no)
IE (1) IE58686B1 (no)
NO (1) NO170516C (no)
NZ (1) NZ214544A (no)
WO (1) WO1986003750A1 (no)
ZA (1) ZA859631B (no)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR890000664B1 (ko) * 1981-10-19 1989-03-22 바리 안소니 뉴우샘 미분된 베클로메타손 디프로피오네이트 일수화물의 제조방법
DE4003270A1 (de) * 1990-02-03 1991-08-08 Boehringer Ingelheim Kg Neue treibgase und ihre verwendung in arzneimittelzubereitungen
US5118494A (en) * 1990-03-23 1992-06-02 Minnesota Mining And Manufacturing Company Use of soluble fluorosurfactants for the preparation of metered-dose aerosol formulations
JP2854974B2 (ja) * 1990-06-29 1999-02-10 フアイソンズ・ピーエルシー 加圧エアロゾル組成物
MX9203481A (es) 1990-10-18 1992-07-01 Minnesota Mining & Mfg Formulaciones.
ATE114112T1 (de) * 1990-10-18 1994-12-15 Minnesota Mining & Mfg Aerosolzubereitung, die beclometason 17,21- dipropionat enthält.
IL104068A (en) * 1991-12-12 1998-10-30 Glaxo Group Ltd Surfactant-free pharmaceutical aerosol formulation comprising 1,1,1,2-tetrafluoroethane or 1,1,1,2,3,3,3-heptafluoro-n- propane as propellant
US5916540A (en) 1994-10-24 1999-06-29 Glaxo Group Limited Aerosol formulations containing P134A and/or P227 and particulate medicament
JP3026841B2 (ja) * 1991-12-12 2000-03-27 グラクソ、グループ、リミテッド 医 薬
TW244350B (no) * 1991-12-14 1995-04-01 Hoechst Ag
DK0717987T3 (da) 1991-12-18 2001-11-12 Minnesota Mining & Mfg Suspension-aerosol-formuleringer
US7101534B1 (en) 1991-12-18 2006-09-05 3M Innovative Properties Company Suspension aerosol formulations
US7105152B1 (en) 1991-12-18 2006-09-12 3M Innovative Properties Company Suspension aerosol formulations
US5202110A (en) * 1992-01-22 1993-04-13 Virginia Commonwealth University Formulations for delivery of beclomethasone diproprionate by metered dose inhalers containing no chlorofluorocarbon propellants
GB9202519D0 (en) * 1992-02-06 1992-03-25 Glaxo Group Ltd Medicaments
US5833950A (en) * 1992-07-31 1998-11-10 Glaxo Group Limited Aerosol formulations containing beclomethasone dipropionate-1, 1, 1, 2-tetrafluoroethane solvate
MX9304585A (es) 1992-07-31 1994-03-31 Glaxo Group Ltd Formulacion farmaceutica en aerosol, lata adecuada para liberar la formulacion e inhalador de dosis dosificada que comprende la lata.
US6013245A (en) * 1995-01-26 2000-01-11 Glaxo Group Limited Aerosol formulation containing beclomethasone dipropionate and 1,1,1,2,3,3,3-heptafluoro-n-propane as propellant
US5747001A (en) * 1995-02-24 1998-05-05 Nanosystems, L.L.C. Aerosols containing beclomethazone nanoparticle dispersions
AU4990696A (en) * 1995-02-24 1996-09-11 Nanosystems L.L.C. Aerosols containing nanoparticle dispersions
DE69724420T2 (de) * 1996-04-29 2004-06-09 Quadrant Technologies Ltd. Verfahren zum inhalieren trockener pulver
GB9826286D0 (en) * 1998-12-01 1999-01-20 Rhone Poulence Rorer Limited Process
JP4700160B2 (ja) 2000-03-13 2011-06-15 株式会社半導体エネルギー研究所 半導体装置
JP4683688B2 (ja) 2000-03-16 2011-05-18 株式会社半導体エネルギー研究所 液晶表示装置の作製方法
GB0208742D0 (en) 2002-04-17 2002-05-29 Bradford Particle Design Ltd Particulate materials
US7582284B2 (en) 2002-04-17 2009-09-01 Nektar Therapeutics Particulate materials
US7811606B2 (en) * 2003-04-16 2010-10-12 Dey, L.P. Nasal pharmaceutical formulations and methods of using the same
US9808471B2 (en) 2003-04-16 2017-11-07 Mylan Specialty Lp Nasal pharmaceutical formulations and methods of using the same
US8912174B2 (en) 2003-04-16 2014-12-16 Mylan Pharmaceuticals Inc. Formulations and methods for treating rhinosinusitis
EP1663159A4 (en) * 2003-09-10 2010-06-09 Map Pharmaceuticals Inc AEROSOL FORMULATIONS FOR THE DELIVERY OF DIHYDROERGOTAMINE TO THE SYSTEMIC CIRCULATION BY PULMONARY INHALATION
US20070286814A1 (en) * 2006-06-12 2007-12-13 Medispray Laboratories Pvt. Ltd. Stable aerosol pharmaceutical formulations
PL2425820T3 (pl) * 2007-02-11 2015-08-31 Map Pharmaceuticals Inc Sposób terapeutycznego stosowania dhe w celu umożliwienia szybkiego złagodzenia migreny przy jednoczesnym zminimalizowaniu profilu działań niepożądanych
PT2435025T (pt) 2009-05-29 2016-11-11 Pearl Therapeutics Inc Administração, por via respiratória, de agentes activos
US8815258B2 (en) 2009-05-29 2014-08-26 Pearl Therapeutics, Inc. Compositions, methods and systems for respiratory delivery of two or more active agents
US20110171141A1 (en) * 2009-06-26 2011-07-14 Kellerman Donald J Administration of dihydroergotamine mesylate particles using a metered dose inhaler
JP6158588B2 (ja) 2012-05-31 2017-07-05 株式会社半導体エネルギー研究所 発光装置
JP6454323B2 (ja) 2013-03-15 2019-01-16 パール セラピューティクス，インコーポレイテッド 粒子状結晶性材料のコンディショニングのための方法及びシステム

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1429184A (en) * 1972-04-20 1976-03-24 Allen & Hanburys Ltd Physically anti-inflammatory steroids for use in aerosols
IL60128A (en) 1979-05-21 1984-01-31 Syntex Corp Preparation of a unique crystalline form of flunisolide
IT1121513B (it) * 1979-05-28 1986-04-02 Chiesi Farma Spa Processo per la conversione di umo steroide antiinfiammatorio in una forma suscettibile di essere somministarta come aerosol
EP0039369B1 (en) * 1980-05-02 1983-06-15 Schering Corporation Beclomethasone ester solvates, process for their preparation, and preparation of a formulation
GB2107715B (en) * 1981-10-19 1985-11-13 Glaxo Group Ltd Micronised beclomethasone dipropionate monohydrate and powder inhalation compositions containing it
KR880001237B1 (ko) * 1984-07-25 1988-07-12 호비온 인터 리미티드 베클로메타손 17,21-디프로피오네이트의 용매화합물의 제조방법

Also Published As

Publication number Publication date
DE3568334D1 (en) 1989-03-30
GB8432063D0 (en) 1985-01-30
ES8702136A1 (es) 1986-12-16
ZA859631B (en) 1987-05-27
NO170516C (no) 1992-10-28
WO1986003750A1 (en) 1986-07-03
IE58686B1 (en) 1993-11-03
US4810488A (en) 1989-03-07
IE853231L (en) 1986-06-19
EP0205530B1 (en) 1989-02-22
JPH0714880B2 (ja) 1995-02-22
KR910004338B1 (ko) 1991-06-26
NZ214544A (en) 1989-04-26
JPS62501706A (ja) 1987-07-09
NO170516B (no) 1992-07-20
ES550076A0 (es) 1986-12-16
CA1253806A (en) 1989-05-09
AU587010B2 (en) 1989-08-03
AU5308786A (en) 1986-07-22
KR870700070A (ko) 1987-02-28
NO863321D0 (no) 1986-08-18
EP0205530A1 (en) 1986-12-30

Similar Documents

Publication Publication Date Title
NO863321D0 (no) Fysikalsk modifisert beclomethasondipropionat egnet for anvendelse i aerosoler.
DE3382547D1 (de) Sekretorische expression in eukaryoten.
FI853313L (fi) Speciallins foer glasoegon.
FI854811A7 (fi) Skaerhuvud foer traodkapare.
ES539731A0 (es) Perfeccionamientos en calandrias
FI864634A7 (fi) Flytande diskmedel foer diskning foer hand i kallt vatten.
FI853891A7 (fi) Puriinijohdannaiset.
FI852573L (fi) Foerbaettringar i anslutning till hjaelpmedel foer handikappade.
FI893497A0 (fi) Elektrokemisk cell med dubbelverkande elektrod.
FI820427L (fi) Foerbindning foer in i varandra gripande metall- eller plastprofiler
FI860611A7 (fi) Anordning i skaerbraennare.
FI850783L (fi) Gasutvecklingsanordning med flere i en tryckgasbehaollare insatta gasflaskor.
FI851586A7 (fi) 3-substituoidut tiopyronit.
DK391786A (da) Fysisk modificeret beclomethasondipropionat egnet til anvendelse i aerosoler
KR860004850U (ko) 성냥개비 정렬 공급장치
FI851796A0 (fi) Kamflaenskonstruktion foer fastsaettning av tvao in i varandra placerbara roerformiga stycken.
NL186107C (nl) Kleding-reinigingsbedrijf.
FI854369A0 (fi) Styranordning foer plasmagenerator.
FI843699A7 (fi) Framstaellningstrumma foer asfaltmassa.
FI875494A0 (fi) Anordning foer lastbehandling i hamnar.
IT8404258V0 (it) Contenitore in particolare per minuterie in genere.
IT8420644V0 (it) Carburatore in particolare per modellismo.
ES282077Y (es) Recipiente perfeccionado.
ES282075Y (es) Envase perfeccionado.
ES283707Y (es) Envase perfeccionado.

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees

Free format text: LAPSED IN JUNE 2003